2022
HIV-Positive Men Are More Likely to Be Hyper Linked Within College Student Social Network — Northeast China, 2017–2018
Li M, Wu H, Yan H, Zunong J, Hui H, Li H, Yang Z, Vermund S, Hu Y. HIV-Positive Men Are More Likely to Be Hyper Linked Within College Student Social Network — Northeast China, 2017–2018. China CDC Weekly 2022, 4: 951-955. PMID: 36483793, PMCID: PMC9713575, DOI: 10.46234/ccdcw2022.195.Peer-Reviewed Original ResearchPositive prevalenceNew human immunodeficiency virus (HIV) infectionsHuman immunodeficiency virus (HIV) infectionHIV incident infectionsHIV-seronegative MSMImmunodeficiency virus infectionHIV-positive MSMHIV-positive menPublic health practiceIncident infectionsRisky sexual behaviorHIV transmissionHIV preventionYoung MSMVirus infectionDisproportionate burdenHealth practicesMSMSocial contactOnline interventionSexual behaviorInfectionMenPrevalenceIncidence
2021
Human Immunodeficiency Virus Infection and Incident Heart Failure: A Meta-Analysis of Prospective Studies
Chen Y, Gao Y, Zhou Y, Li X, Wang H, Polonsky TS, Vermund SH, Qian HZ, Qian F. Human Immunodeficiency Virus Infection and Incident Heart Failure: A Meta-Analysis of Prospective Studies. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2021, 87: 741-749. PMID: 33492019, PMCID: PMC10768809, DOI: 10.1097/qai.0000000000002629.Peer-Reviewed Original ResearchConceptsIncident heart failureLow CD4 countHeart failureHIV infectionRandom-effects modelCD4 countSubgroup analysisRisk of HFHuman immunodeficiency virus (HIV) infectionLaird random-effects modelYoung adultsAvailable prospective evidenceImmunodeficiency virus infectionPooled relative riskFull-text assessmentWeb of ScienceFixed-effects modelProspective studyIncident casesProspective evidenceRelative riskVirus infectionFunnel plotMeta-AnalysisSimilar associationAssociation of HIV infection and cognitive impairment in older adults: A meta-analysis
Deng L, Zhang X, Gao Y, Turner D, Qian F, Lu H, Vermund SH, Zhang Y, Qian HZ. Association of HIV infection and cognitive impairment in older adults: A meta-analysis. Ageing Research Reviews 2021, 68: 101310. PMID: 33640473, PMCID: PMC10767715, DOI: 10.1016/j.arr.2021.101310.Peer-Reviewed Original ResearchConceptsHIV infectionCognitive impairmentOlder adultsOdds ratioHuman immunodeficiency virus (HIV) infectionMean differenceMotor/psychomotorImmunodeficiency virus infectionMajor cognitive domainsNewcastle-Ottawa ScaleConfidence intervalsRisk of biasPooled odds ratioCross-sectional studyRandom-effects modelIncome countriesCognitive domainsGlobal cognitive impairmentExecutive functionOlder PLWHVirus infectionHigh-income countriesHIVPLWHUpper middle-income countries
2019
Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART)
Hayes RJ, Donnell D, Floyd S, Mandla N, Bwalya J, Sabapathy K, Yang B, Phiri M, Schaap A, Eshleman SH, Piwowar-Manning E, Kosloff B, James A, Skalland T, Wilson E, Emel L, Macleod D, Dunbar R, Simwinga M, Makola N, Bond V, Hoddinott G, Moore A, Griffith S, Deshmane Sista N, Vermund SH, El-Sadr W, Burns DN, Hargreaves JR, Hauck K, Fraser C, Shanaube K, Bock P, Beyers N, Ayles H, Fidler S. Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART). New England Journal Of Medicine 2019, 381: 207-218. PMID: 31314965, PMCID: PMC6587177, DOI: 10.1056/nejmoa1814556.Peer-Reviewed Original ResearchConceptsHIV-positive participantsViral suppressionHIV infectionGroup BGroup AGroup CMonth 12Universal testingPrevention interventionsPopulation cohortHuman immunodeficiency virus (HIV) infectionHome-based HIV testingBaseline HIV prevalenceCombination prevention interventionsImmunodeficiency virus infectionHIV-positive adultsPopulation-level incidenceNew HIV infectionsAdjusted rate ratiosCommunity-randomized trialLack of effectHIV carePrevious trial resultsStandard careART adherence
2018
Prevalent Misconceptions About Opioid Use Disorders in the United States Produce Failed Policy and Public Health Responses
Heimer R, Hawk K, Vermund SH. Prevalent Misconceptions About Opioid Use Disorders in the United States Produce Failed Policy and Public Health Responses. Clinical Infectious Diseases 2018, 69: 546-551. PMID: 30452633, PMCID: PMC6637277, DOI: 10.1093/cid/ciy977.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionChronic pain medicationsNonopioid pain managementImmunodeficiency virus infectionPrescribing of opioidsOpioid use disorderCurrent opioid crisisEvidence-based therapiesOpioid overdose mortalityPublic health responseOpioid prescribingPain medicationHepatitis BPain managementC virusVirus infectionOpioid addictionOverdose mortalityUse disordersOral consumptionHealth professionalsOpioid crisisHealth responseOpioidsPrescribing
2012
HIV Epidemic
Vermund S. HIV Epidemic. Emerging Infectious Diseases Of The 21st Century 2012, 3-46. DOI: 10.1007/978-1-4614-4496-1_1.Peer-Reviewed Original ResearchHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionEra of antibioticsGlobal pandemicHIV epidemicVirus infectionSusceptible humansEpidemic formHIVDevastating diseaseInfectionEpidemicSuccessful controlImproved sanitationPlague bacteriumBubonic plagueYersinia pestisPandemicLess intensityRodent controlDisease
2010
Human Immunodeficiency Virus Infection in Alabama Women: Sociodemographic, Behavioral, and Reproductive Health Characteristics and Factors Associated With Lack of Human Immunodeficiency Virus-1 Viral Control
Bhatta MP, Hoesley C, Vermund S. Human Immunodeficiency Virus Infection in Alabama Women: Sociodemographic, Behavioral, and Reproductive Health Characteristics and Factors Associated With Lack of Human Immunodeficiency Virus-1 Viral Control. The American Journal Of The Medical Sciences 2010, 339: 133-140. PMID: 20087169, DOI: 10.1097/maj.0b013e3181c300f9.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionBehavioral risk factorsViral controlAlabama womenRisk factorsVirus infectionBlack race/ethnicityT-cell countsCells/microLOutpatient HIV clinicHIV-1 controlReproductive health characteristicsLow viral loadHIV-1 diagnosisBlack womenSelf-administered questionnaireRace/ethnicityAnnual household incomeCervicovaginal lavageAntiretroviral therapyHIV clinicHIV infectionHIV testingSuboptimal access
2001
Cervical Ectopy in Adolescent Girls with and without Human Immunodeficiency Virus Infection
Moscicki A, Ma Y, Holland C, Vermund S. Cervical Ectopy in Adolescent Girls with and without Human Immunodeficiency Virus Infection. The Journal Of Infectious Diseases 2001, 183: 865-870. PMID: 11237802, DOI: 10.1086/319261.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionHIV infectionLifetime sex partnersVirus infectionAdolescent girlsSex partnersMultivariate logistic regression analysisOral contraceptive useLogistic regression analysisCervical ectopyBacterial vaginosisNegative adolescentsUnivariate analysisContraceptive useChlamydia trachomatisNeisseria gonorrhoeaeInfectionSignificant predictorsEctopyCervixRegression analysisOngoing studiesMore partnersGirls
2000
T-Lymphocyte Subsets in HIV-Infected and High-Risk HIV-Uninfected Adolescents: Retention of Naive T Lymphocytes in HIV-Infected Adolescents
Douglas SD, Rudy B, Muenz L, Starr SE, Campbell DE, Wilson C, Holland C, Crowley-Nowick P, Vermund SH. T-Lymphocyte Subsets in HIV-Infected and High-Risk HIV-Uninfected Adolescents: Retention of Naive T Lymphocytes in HIV-Infected Adolescents. JAMA Pediatrics 2000, 154: 375-380. PMID: 10768676, DOI: 10.1001/archpedi.154.4.375.Peer-Reviewed Original ResearchConceptsHIV-negative youthHuman immunodeficiency virus-infected adolescentsT lymphocyte subsetsNaive CD8Total CD4Immune systemCell countHIV infectionAdolescent careAdolescent Medicine HIV/AIDS Research NetworkHuman immunodeficiency virus (HIV) infectionHealth ProjectActive antiretroviral therapyCohort of HIVPercentage of CD4HIV-negative controlsHIV-positive subjectsImmunodeficiency virus infectionAIDS Research NetworkHigh-risk HIVT lymphocyte responsesHIV-negative adolescentsNaive T lymphocytesMemory cell populationsSignificant increase
1995
Risk Factors for HTLV-I Among Heterosexual STD Clinic Attenders
Figueroa JP, Morris J, Brathwaite A, Ward E, Peruga A, Hayes R, Vermund SH, Blattner W. Risk Factors for HTLV-I Among Heterosexual STD Clinic Attenders. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 9: 81-88. PMID: 7712238, DOI: 10.1097/00042560-199505010-00012.Peer-Reviewed Original ResearchConceptsFirst sexual intercourseHuman immunodeficiency virus (HIV) infectionMultiple logistic regression analysisHepatitis B surface antigenSexual intercourseImmunodeficiency virus infectionMore lifetime sexual partnersSTD clinic attendersHTLV-I infectionB surface antigenLogistic regression analysisLifetime sexual partnersMore sex partnersBlood transfusionClinic attendersDisease clinicIndependent associationRisk factorsVirus infectionPositive testSurface antigenSex partnersSexual partnersHTLVMarital status
1994
Risk Factors For Squamous Intraepithelial Lesions On Pap Smear In Women At Risk For Human Immunodeficiency Virus Infection
Klein R, Ho G, Vermund S, Fleming I, Burk R. Risk Factors For Squamous Intraepithelial Lesions On Pap Smear In Women At Risk For Human Immunodeficiency Virus Infection. The Journal Of Infectious Diseases 1994, 170: 1404-1409. PMID: 7995978, DOI: 10.1093/infdis/170.6.1404.Peer-Reviewed Original ResearchMeSH KeywordsAdultCarcinoma, Squamous CellCD4 Lymphocyte CountDNA, ViralFemaleHIV AntibodiesHIV InfectionsHumansImmunocompromised HostMiddle AgedMultivariate AnalysisNew YorkOdds RatioPapanicolaou TestPapillomaviridaePapillomavirus InfectionsPrevalenceRisk FactorsTumor Virus InfectionsUterine Cervical DysplasiaUterine Cervical NeoplasmsVaginal SmearsConceptsSquamous intraepithelial lesionsHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionRisk factorsHPV infectionHIV infectionIntraepithelial lesionsPap smearVirus infectionHigh-risk HPV typesGenital HPV infectionHIV antibody testingIndependent risk factorSevere HIVSevere immunosuppressionHPV typesAntibody testingGenital HPVUnivariate analysisMultivariate analysisInfectionGenome detectionImmunosuppressionRiskLesionsNIH conference. HIV vaccine development: a progress report.
Hoth DF, Bolognesi DP, Corey L, Vermund SH. NIH conference. HIV vaccine development: a progress report. Annals Of Internal Medicine 1994, 121: 603-11. PMID: 8085693, DOI: 10.7326/0003-4819-121-8-199410150-00008.Peer-Reviewed Original ResearchConceptsVaccine candidatesAnimal modelsHuman immunodeficiency virus (HIV) infectionCytotoxic T cell responsesLarge-scale efficacy trialsInnovative vaccine candidatesImmunodeficiency virus infectionT cell responsesCorrelates of immunityEffective preventive vaccineProtective immune responseDiversity of HIVHIV vaccine researchHuman phase IPromising vaccine candidateUseful animal modelPreventive vaccineEfficacy trialsVirus infectionImmune responseVaccine researchSuch trialsPhase ITrialsHIVRising HIV-1 prevalence among sexually transmitted disease clinic attenders in Jamaica: traumatic sex and genital ulcers as risk factors.
Figueroa JP, Brathwaite A, Morris J, Ward E, Peruga A, Blattner W, Vermund SH, Hayes R. Rising HIV-1 prevalence among sexually transmitted disease clinic attenders in Jamaica: traumatic sex and genital ulcers as risk factors. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1994, 7: 310-6. PMID: 8106971.Peer-Reviewed Original ResearchConceptsGenital ulcersHIV infectionSyphilis serologyHIV Type 1 InfectionHuman immunodeficiency virus (HIV) infectionMultiple logistic regression analysisHIV-1 prevalenceImmunodeficiency virus infectionType 1 infectionComprehensive health centersLogistic regression analysisDisease clinic attendersHeterosexual menMore sex partnersDisease complaintsClinic attendersIndependent associationRisk factorsHealth centersVirus infectionPresent complaintsSex partnersUlcersAge adjustmentPast month
1992
The Effects on Survival of Early Treatment of Human Immunodeficiency Virus Infection
Graham N, Zeger S, Park L, Vermund S, Detels R, Rinaldo C, Phair J. The Effects on Survival of Early Treatment of Human Immunodeficiency Virus Infection. New England Journal Of Medicine 1992, 326: 1037-1042. PMID: 1347907, DOI: 10.1056/nejm199204163261601.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionImmunodeficiency virus infectionDevelopment of AIDSPneumocystis carinii pneumoniaPCP prophylaxisProlong survivalEarly treatmentRelative riskVirus infectionCell countUse of zidovudineUse of prophylaxisDiagnosis of AIDSHIV Type 1HIV-1 infectionBasis of CD4High-risk menInitial disease stateProbability of deathZidovudine usersZidovudine therapyImmunodeficiency syndromeCarinii pneumoniaClinical symptomsProphylaxisAssociation of Mycoplasma and Human Immunodeficiency Virus Infection: Detection of Amplified Mycoplasma fermentans DNA in Blood
Hawkins R, Rickman L, Vermund S, Carl M. Association of Mycoplasma and Human Immunodeficiency Virus Infection: Detection of Amplified Mycoplasma fermentans DNA in Blood. The Journal Of Infectious Diseases 1992, 165: 581-585. PMID: 1538164, DOI: 10.1093/infdis/165.3.581.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionM. fermentans infectionImmunodeficiency virus infectionVirus infectionHIV clinical stageMycoplasma fermentans infectionHIV-seronegative subjectsHIV-seropositive patientsCross-sectional studyHistory of syphilisAssociation of MycoplasmaHIV infectionOpportunistic infectionsClinical stageLower riskNonsignificant trendPolymerase chain reaction methodologyInfectionPatientsBloodM. fermentansAssociationCopathogensHIVSyphilisCD4+ Lymphocyte Cell Enumeration for Prediction of Clinical Course of Human Immunodeficiency Virus Disease: A Review
Stein D, Korvick J, Vermund S. CD4+ Lymphocyte Cell Enumeration for Prediction of Clinical Course of Human Immunodeficiency Virus Disease: A Review. The Journal Of Infectious Diseases 1992, 165: 352-363. PMID: 1346152, DOI: 10.1093/infdis/165.2.352.Peer-Reviewed Original ResearchConceptsCell countHuman immunodeficiency virus (HIV) diseaseHuman immunodeficiency virus (HIV) infectionIntercurrent viral infectionPractical clinical perspectiveProgressive infectious processImmunodeficiency virus infectionImportant therapeutic decisionsAIDS CommentaryInfluence of drugsT helperClinical courseHIV infectionSurrogate markerTherapeutic decisionsVirus infectionInfectious processViral infectionCD4Clinical perspectiveEnd stageInfectionNational InstituteVirus diseaseCountGenital papillomavirus infection and cervical dysplasia—opportunistic complications of hiv infection
Laga M, Icenogle J, Marsella R, Manoka A, Nzila N, Ryder R, Vermund S, Heyward W, Nelson A, Reeves W. Genital papillomavirus infection and cervical dysplasia—opportunistic complications of hiv infection. International Journal Of Cancer 1992, 50: 45-48. PMID: 1309459, DOI: 10.1002/ijc.2910500110.Peer-Reviewed Original ResearchConceptsCervical intra-epithelial neoplasiaHuman genital papillomavirusesHPV infectionOpportunistic complicationsSeronegative womenHIV infectionHPV typesCervical cancerPap smearHuman immunodeficiency virus (HIV) infectionHIV-seropositive womenHPV DNA testingImmunodeficiency virus infectionIntra-epithelial neoplasiaGenital papillomavirus infectionAno-genital cancersGenital HPV typesCervicovaginal lavageSeropositive womenHIV seropositivityPapillomavirus infectionCervical diseaseCervical dysplasiaHPV DNAImmunodeficiency syndrome
1991
High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection
Vermund S, Kelley K, Klein R, Feingold A, Schreiber K, Munk G, Burk R. High risk of human papillomavirus infection and cervical squamous intraepithelial lesions among women with symptomatic human immunodeficiency virus infection. American Journal Of Obstetrics And Gynecology 1991, 165: 392-400. PMID: 1651648, DOI: 10.1016/0002-9378(91)90101-v.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus (HIV) infectionSquamous intraepithelial lesionsHuman papillomavirus infectionImmunodeficiency virus infectionSymptomatic human immunodeficiency virus infectionHuman immunodeficiency virusIntraepithelial lesionsPapillomavirus infectionVirus infectionUninfected womenImmunodeficiency virusHigh riskHuman immunodeficiency virus-infected womenHuman immunodeficiency virus-related diseaseHuman immunodeficiency virus seropositiveCervical squamous intraepithelial lesionsHigh-risk womenCervical cytologic abnormalitiesVirus-related diseasesPublic health measuresAssociated immunosuppressionAsymptomatic womenCytologic abnormalitiesHuman papillomavirusHealth measuresNational AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups.
Rosenberg PS, Gail MH, Schrager LK, Vermund SH, Creagh-Kirk T, Andrews EB, Winkelstein W, Marmor M, Des Jarlais DC, Biggar RJ. National AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1991, 4: 392-401. PMID: 2007974.Peer-Reviewed Original ResearchConceptsIntravenous drug usersAIDS incidence trendsIncidence trendsDrug usersHeterosexual contactSevere immunodeficiencyHeterosexual intravenous drug usersHuman immunodeficiency virus (HIV) infectionFavorable trendTransmission groupImmunodeficiency virus infectionIncidence of AIDSCases of AIDSZidovudine therapyTransfusion recipientsVirus infectionNumber of casesZidovudineNew York CityEarly cessationTherapyAIDSMenGay menSan Francisco
1990
How can epidemiology assist in guiding interventions for the acquired immunodeficiency syndrome/human immunodeficiency virus?
Vermund S, Hoth D. How can epidemiology assist in guiding interventions for the acquired immunodeficiency syndrome/human immunodeficiency virus? Annals Of Epidemiology 1990, 1: 141-155. PMID: 1669495, DOI: 10.1016/1047-2797(90)90005-d.Peer-Reviewed Original ResearchConceptsNew therapiesHIV infectionTherapeutic trialsClinical trialsImmunodeficiency syndrome/human immunodeficiency virusVaccine developmentHuman immunodeficiency virus (HIV) infectionRecent drug trialsImmunodeficiency virus infectionDevelopment of AIDSHost immunologic responseHuman immunodeficiency virusSuch clinical parametersFuture epidemiologic researchClinical therapeutic researchNatural history studiesUse of condomsEffect of treatmentClinical research methodsVariety of treatmentsAIDS/HIV epidemicClinical courseClinical outcomesClinical parametersImmunodeficiency virus